SHELLY MAXWELL: Open Payments
NPI 1457035933 · BAY CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 12 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $636 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $175 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: Wegovy, FARXIGA, GVOKE HYPOPEN, TRELEGY ELLIPTA, REXULTI.
Industry payments across MI — which companies pay providers there.
